CLINICAL_TRIALS
trial_result
· 2020-01-13
Clinical Trial Update: Choline Alphoscerate-Nimodipine in Vascular Cognitive Impairment [Phase 2]
Summary
Phase 2 trial update for choline alphoscerate-nimodipine in vascular cognitive impairment has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Azienda Ospedaliero-Universitaria Careggi | Conditions: Vascular Cognitive Impairment | Phase 2 | Status: COMPLETED